secwatch / observer
8-K filed June 15, 2023, 7:59 PM ET ticker ANAB CIK 0001370053
other confidence high sentiment neutral materiality 0.15

AnaptysBio shareholders elect three directors, ratify KPMG, approve executive pay, and amend charter

ANAPTYSBIO, INC

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 1.0

ANAPTYSBIO, INC shareholders approved Non-binding, advisory approval of compensation paid to the Company's named executive officers at the 2023-06-15 meeting.

Proposal
say on pay
Outcome
passed
Meeting
2023-06-15
Exact text from the filing
3. Non-binding, advisory approval of compensation paid to the Company’s named executive officers: Shares For Shares Against Shares Withheld/Abstaining Broker Non-Votes 15,221,869 7,185,726 2,237 2,247,178
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 1.0

ANAPTYSBIO, INC shareholders approved Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-06-15 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2023-06-15
Exact text from the filing
2. Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023: Shares For Shares Against Shares Withheld/Abstaining Broker Non-Votes 24,453,643 203,193 174 —
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 1.0

ANAPTYSBIO, INC shareholders approved Election of three Class III directors, Magda Marquet, Ph.D., Hollings Renton, M.B.A., and John P. Schmid, each to serve a three-year term at the 2023-06-15 meeting.

Proposal
director election
Outcome
passed
Meeting
2023-06-15
Exact text from the filing
1. Election of three Class III directors, Magda Marquet, Ph.D., Hollings Renton, M.B.A., and John P. Schmid, each to serve a three-year term, which will expire at the 2026 Annual Meeting of Stockholders or until such time as his or her respective successor has been duly elected and qualified or until such director’s earlier resignation or removal: Nominees Shares For Shares Withheld / Abstaining Broker Non-Votes Magda Marquet, Ph.D. 21,553,117 856,715 2,247,178 Hollings Renton, M.B.A. 16,883,226 5,526,606 2,247,178 John P. Schmid 20,391,333 2,018,499 2,247,178
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 1.0

ANAPTYSBIO, INC shareholders approved Approval of the Amended and Restated Certificate of Incorporation permitting the exculpation of officers at the 2023-06-15 meeting.

Proposal
charter amendment
Outcome
passed
Meeting
2023-06-15
Exact text from the filing
4. Approval of the Amended and Restated Certificate of Incorporation permitting the exculpation of officers: Shares For Shares Against Shares Withheld/Abstaining Broker Non-Votes 21,803,870 605,555 407 2,247,178
View on SEC.gov

1181 shareholder votes filed in the last 30 days. Browse all shareholder votes →

ANAPTYSBIO, INC filing history →

Source: SEC EDGAR
accession 0001370053-23-000043
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.